BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 33119842)

  • 1. Comparing the extent of breast cancer tumors through contrast-enhanced ultrasound vs B-mode, opposed with pathology: evergreen study.
    Shima H; Okuno T; Nakamura T; Noro A; Noma M; Sato M; Kaga T; Mituzuka Y; Kamei K; Imayoshi Y; Ito T; Kanazawa S; Kato K; Kutomi G; Sekiguchi R; Mori M; Tadashi H; Hirai T; Takemasa I
    Breast Cancer; 2021 Mar; 28(2):405-413. PubMed ID: 33119842
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of background parenchymal enhancement in breast contrast-enhanced ultrasound with Sonazoid
    Haga M; Hirai T; Nakai T; Kobayashi T; Nakamura T; Marugami A; Ito T; Takewa M; Marugami N; Kichikawa K
    J Med Ultrason (2001); 2020 Oct; 47(4):591-601. PubMed ID: 32989596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The detection of pCR after PST by contrast-enhanced ultrasonography for breast cancer.
    Fujisawa T; Hirakata T; Yanagita Y; Iijima M; Horikoshi H; Takeuchi K; Saitoh Y
    Breast Cancer; 2013 Jan; 20(1):75-82. PubMed ID: 22203579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative Multiparametric Breast Ultrasound: Application of Contrast-Enhanced Ultrasound and Elastography Leads to an Improved Differentiation of Benign and Malignant Lesions.
    Kapetas P; Clauser P; Woitek R; Wengert GJ; Lazar M; Pinker K; Helbich TH; Baltzer PAT
    Invest Radiol; 2019 May; 54(5):257-264. PubMed ID: 30632985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of parametric imaging on contrast-enhanced ultrasound of breast cancer.
    Noro A; Nakamura T; Hirai T; Haga M; Kobayashi T; Hayashi A; Kozuka Y; Nakai T; Ogura T; Ogawa T
    J Med Ultrason (2001); 2016 Apr; 43(2):227-35. PubMed ID: 26801662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Accuracy of conventional ultrasound, contrast-enhanced ultrasound and dynamic contrast-enhanced magnetic resonance imaging in assessing the size of breast cancer.
    Shi XQ; Dong Y; Tan X; Yang P; Wang C; Feng W; Lin Y; Qian L
    Clin Hemorheol Microcirc; 2022; 82(2):157-168. PubMed ID: 35723092
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnosis of sub-centimetre breast lesions: combining BI-RADS-US with strain elastography and contrast-enhanced ultrasound-a preliminary study in China.
    Xiao X; Jiang Q; Wu H; Guan X; Qin W; Luo B
    Eur Radiol; 2017 Jun; 27(6):2443-2450. PubMed ID: 27761708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic value of contrast-enhanced ultrasound and shear-wave elastography for breast lesions of sub-centimeter.
    Xiang LH; Yao MH; Xu G; Pu H; Liu H; Fang Y; Wu R
    Clin Hemorheol Microcirc; 2017; 67(1):69-80. PubMed ID: 28482623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of sonazoid (perflubutane) for contrast-enhanced ultrasound in the differentiation of focal breast lesions: phase 3 multicenter clinical trial.
    Miyamoto Y; Ito T; Takada E; Omoto K; Hirai T; Moriyasu F
    AJR Am J Roentgenol; 2014 Apr; 202(4):W400-7. PubMed ID: 24660739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preoperative sentinel lymph node identification, biopsy and localisation using contrast enhanced ultrasound (CEUS) in patients with breast cancer: a systematic review and meta-analysis.
    Nielsen Moody A; Bull J; Culpan AM; Munyombwe T; Sharma N; Whitaker M; Wolstenhulme S
    Clin Radiol; 2017 Nov; 72(11):959-971. PubMed ID: 28774472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Application of contrast-enhanced ultrasound in the diagnosis of small breast lesions.
    Du YR; Wu Y; Chen M; Gu XG
    Clin Hemorheol Microcirc; 2018; 70(3):291-300. PubMed ID: 29710688
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Variation of sentinel lymphatic channels (SLCs) and sentinel lymph nodes (SLNs) assessed by contrast-enhanced ultrasound (CEUS) in breast cancer patients.
    Wang Y; Zhou W; Li C; Gong H; Li C; Yang N; Zha X; Chen L; Xia T; Liu X; Wang M; Ding Q
    World J Surg Oncol; 2017 Jul; 15(1):127. PubMed ID: 28693494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Application of Contrast-Enhanced Ultrasound in the Diagnosis of Ductal Carcinoma In Situ: Analysis of 127 Cases.
    Li W; Zhou Q; Xia S; Wu Y; Fei X; Wang Y; Tao L; Fan J; Zhou W
    J Ultrasound Med; 2020 Jan; 39(1):39-50. PubMed ID: 31206200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Homogeneously enhancing breast lesions on contrast enhanced US: differential diagnosis by conventional and contrast enhanced US findings.
    Fujimitsu R; Shimakura M; Urakawa H; Morita A; Shinagawa Y; Sakamoto K; Yoshimitsu K
    Jpn J Radiol; 2016 Jul; 34(7):508-14. PubMed ID: 27142527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative contrast-enhanced ultrasound evaluation of pathological complete response in patients with locally advanced breast cancer receiving neoadjuvant chemotherapy.
    Wan CF; Liu XS; Wang L; Zhang J; Lu JS; Li FH
    Eur J Radiol; 2018 Jun; 103():118-123. PubMed ID: 29803376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Accuracy of tumor size measurement: comparison of B-mode ultrasound, strain elastography, and 2D and 3D shear wave elastography with histopathological lesion size.
    Farrokh A; Maass N; Treu L; Heilmann T; Schäfer FK
    Acta Radiol; 2019 Apr; 60(4):451-458. PubMed ID: 30043622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contrast-enhanced ultrasound using real-time contrast harmonic imaging in invasive breast cancer: comparison of enhancement dynamics with three different doses of contrast agent.
    Saracco A; Szabó BK; Aspelin P; Leifland K; Tánczos E; Wilczek B; Axelsson R
    Acta Radiol; 2015 Jan; 56(1):34-41. PubMed ID: 24445092
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pitfalls of Contrast Enhanced Ultrasound (CEUS) in determination of breast tumor biological dignity.
    Lehotska V; Rauova K; Vanovcanova L
    Neoplasma; 2018; 65(1):124-131. PubMed ID: 29322796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of transducers with different frequencies in breast contrast-enhanced ultrasound (CEUS) using SonoVue as contrast agent.
    Wang YM; Fan W; Zhang K; Zhang L; Tan Z; Ma R
    Br J Radiol; 2016 Jul; 89(1063):20151050. PubMed ID: 27143439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Percutaneous contrast-enhanced ultrasound for localization and diagnosis of sentinel lymph node in early breast cancer.
    Liu J; Liu X; He J; Gou B; Luo Y; Deng S; Wen H; Zhou L
    Sci Rep; 2019 Sep; 9(1):13545. PubMed ID: 31537856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.